Advertisement
Product › Details
Metavax® VLP technology
Next higher product group | VLP technology (virus-like particle technology) | |
Status | 2013-04-22 existent | |
Organisation | Artes Biotechnology GmbH | |
Record changed: 2023-07-10 |
Advertisement
More documents for vaccine technology
- [1] Insilico Biotechnology AG. (8/24/21). "Press Release: Insilico Biotechnology AG Participates in Inno4vac, a European new public-private partnership to innovate vaccine development". Stuttgart....
- [2] SpyBiotech Ltd.. (2/10/21). "Press Release: SpyBiotech Raises $32.5M in Series A funding and Appoints Lutz B. Giebel as Chairman". Oxford....
- [3] SpyBiotech Ltd.. (9/8/20). "Press Release: SpyBiotech and Serum Institute of India Announce that the First Subjects Have Been Dosed in a Phase I/II Trial of a Novel Virus-like Particle Vaccine Targeting COVID-19". Oxford....
- [4] Denka Co. Ltd.. (8/23/17). "Press Release: Denka Completes the Acquisition of Icon Genetics GmbH, a German Bio-pharmaceutical R&D Company, Making It a Wholly Owned Subsidiary"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top